A detailed history of Oracle Alpha Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Oracle Alpha Inc. holds 15,367 shares of NVCR stock, worth $473,303. This represents 0.43% of its overall portfolio holdings.

Number of Shares
15,367
Previous 12,767 20.37%
Holding current value
$473,303
Previous $191 Million 26.01%
% of portfolio
0.43%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$12.42 - $17.29 $32,292 - $44,954
2,600 Added 20.37%
15,367 $240 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $142,096 - $201,463
12,767 New
12,767 $191 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.